0217 Excision
BioCentury & Getty Images

Finance

Eyeing functional cure, Excision raises $60M to advance CRISPR-based HIV program into Phase I/II 

Feb 18, 2021 | 1:48 AM GMT

With primate data in hand for its CRISPR-based HIV therapy, Excision raised a $60 million round to advance into the clinic this year. 

Antiretroviral

Read the full 483 word article

How to gain access

Continue reading with a
two-week free trial.